- Home
- Equipment
- asia middle east
- cell therapy for cellular therapy
Show results for
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Cell Therapy For Cellular Therapy Equipment Supplied In Asia Middle East
50 equipment items found
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Our convenient, automated thawing device, for use by clinicians at point of care, offers a reliable and simple thawing method that can safeguard the integrity of the supply chain. This is key to maintaining the potency and consistency of a cell product, because, unlike many traditional drugs, cell therapies must be thawed before being administered to a patient. However, the most commonly used ...
Manufactured by:Lineage Cell Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
The Lineage Platform begins with an infinitely reproducible cell line. Using our in-house manufacturing abilities and guided differentiation IP, we are able to direct pluripotent cells to become specialized cell types found in the human body, many of which have potential applications in transplant medicine. ...
Manufactured by:LINET spol. s.r.o. based inSlaný, CZECH REPUBLIC
The CliniCare 100 HF with the active and passive system in one for intensive, acute and long-term care. LINET introduces the CliniCare 100 HF for intensive, acute and long-term care with 2 -cell alternating and passive systems which provide effective support for the prevention of pressure ...
Manufactured by:Kangstem Biotech Co., Ltd. based inGangnam-gu, SOUTH KOREA
FURESTEM-AD Inj. is the world’s first stem cell therapeutic product for atopic dermatitis that targets moderate to severe atopic dermatitis ...
Manufactured by:Bioquell PLC, an Ecolab Solution based inAndover, UNITED KINGDOM
The Bioquell Qube is a configurable isolator integrated with Bioquell’s Hydrogen Peroxide Vapor technology. From its unique design to rapid cycle times, the Bioquell Qube ensures your aseptic workspace needs are met for a safe and productive working ...
Manufactured by:Betalin Therapeutics Ltd. based inJerusalem, ISRAEL
Islet transplantation is a widely used cell therapy technique which achieves normoglycemia (normal blood glucose levels) in diabetic patients. However, one of the biggest challenges is early islet cell death, this tends to occur before the transplantation procedure. This is thought to be due to the loss of the islets microenvironment during isolation. The extracellular matrix (ECM, a support ...
Manufactured by:Zhejiang Tailin Bioengineering Co., Ltd. based inBinjiang, Hangzhou, CHINA
Design based on stringent GMP aseptic production requirements and meets the requirements of various regulatory agencies (FDA, EMA, NMPA) regulations and industry guidelines (ISO, PDA, USP, Chinese ...
Manufactured by:Kangstem Biotech Co., Ltd. based inGangnam-gu, SOUTH KOREA
FURESTEM-RA Inj. targets moderate to severe rheumatoid arthritis ...
by:Treefrog Therapeutics based inPessac, FRANCE
$100,000 Funding: We fund your research over 2 years in the academic lab of your choice. You spend the money how you like on your project, so that you can give it your best shot. Just Science: Any PhD level scientist can apply anonymously by submitting a one-page research rationale and a graphical abstract. We select ideas, not resumes. No Hassle: The application process is fast. We don’t ...
Manufactured by:MitoImmune Therapeutics Inc. based inGangnam-gu, SOUTH KOREA
MIT-001 is an innovative clinical candidate that blocks the root cause of graft-versus-host disease, which often occurs during allogenic hematopoietic stem cell transplantation (HSCT), through a mechanism of action that is differentiated from any current ...
Manufactured by:Lineage Cell Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
On December 20, 2021, Lineage announced that it has entered into an exclusive worldwide collaboration and license agreement with Roche and Genentech, a member of the Roche Group, for the development and commercialization of OpRegen for the treatment of ocular disorders, including advanced dry age-related macular degeneration (dry AMD) with geographic atrophy (GA) in a transaction worth up to $670 ...
Manufactured by:Cytena based inFreiburg, GERMANY
Faster than Ever Before: By automating labor-intensive and time-consuming steps, the F.SIGHT 2.0 significantly streamlines Cell Line Development (CLD), Cell & Gene therapy, as well as Single-cell Omics workflows. The F.SIGHT 2.0 is the fastest single-cell dispenser that isolates both unlabeled and green fluorescent cells. With our patented, highly efficient and gentle single-cell technology, ...
Manufactured by:Viscoll based inMoscow, RUSSIA
The product is a soft, pliable, rounded, porous white matrix made of highly purified native type I collagen isolated from porcine tendons. The product is intended for use in surgical procedures that require replacement or repair of the patient’s dura ...
Manufactured by:Antengene Corporation Limited based inChangning District, CHINA
Diffuse large B-cell lymphoma (DLBCL) is one of the most common types of non-Hodgkin lymphoma (NHL) in adults and a highly heterogeneous malignancy in both clinical manifestations and prognosis. DLBCL accounts for 30%-40% of all NHL cases, and over 40% in most Asian ...
by:The Regeneration Center based inBangkok, THAILAND
Autologous stem cells such as Adipose tissue derived stem cells are the opposite of allogenic stem cells, as only one patient stands as both donor and receiver. The stem cells will be harvested from the patient’s body, most common location of which is the bone marrow, and will be transplanted back to the patient for treatment of a variety of conditions including: shoulder injuries, Acute ...
Manufactured by:Kangstem Biotech Co., Ltd. based inGangnam-gu, SOUTH KOREA
FURESTEM-OA Kit Inj., a therapeutic biological product, is composed of allogeneic umbilical cord blood-derived mesenchymal stem cells (FURESTEM-OA Inj.), as a major active component for repairing tissue damage, and cartilage acellular matrix (CAM Inj.), a medical device, as a supportive material. This convergence medical product is under development for the treatment of osteoarthritis patients ...
Manufactured by:Sartorius AG based inGoettingen, GERMANY
The Recombumin® product portfolio are the highest quality, animal and human origin-free recombinant human albumins commercially available. Our highly pure, safe and consistent albumins enable you to formulate with ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-25-IC is Mesoblast’s Phase 2 product candidate for the treatment of acute myocardial infarction. This is the first clinical study to evaluate an allogeneic cellular therapy delivered by intracoronary infusion in patients who have suffered an acute myocardial ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
Remestemcel-L is being developed for inflammatory diseases in children and adults including the treatment of acute graft versus host disease (aGVHD), a potentially life-threatening complication of an allogeneic bone marrow transplant (BMT). Currently, there are no products currently approved in the United States for treatment of steroid-refractory aGVHD in children under 12, and off-label options ...
Manufactured by:Kangstem Biotech Co., Ltd. based inGangnam-gu, SOUTH KOREA
Kangstem Biotech is developing stem cell therapeutic products for patients suffering from rare and incurable diseases using umbilical cord blood-derived stem ...